New Antibiotic Launch by B. Braun Medical Inc.
B. Braun Medical Inc., based in Bethlehem, Pennsylvania, is creating waves in the healthcare sector with the launch of Piperacillin and Tazobactam for Injection, designed specifically for use in its innovative DUPLEX Drug Delivery System. This newly introduced injectable antibiotic is among the most frequently used in the United States, and it comes in three strengths: 2.25 g/50 mL, 3.375 g/50 mL, and 4.5 g/100 mL.
Commitment to Nursing Standards
This launch comes on the heels of being awarded Nurse Approved Certification for Piperacillin and Tazobactam, ensuring that the products align seamlessly with nursing practices. B. Braun's commitment to enhancing usability and workflow is evident as they continually develop solutions crafted around healthcare professionals' needs.
Efficiency and Safety Redefined
The DUPLEX Drug Delivery System is especially crafted for ease of use, featuring a two-compartment design that remains free from DEHP or PVC. It stores both medication and diluent separately until administration, allowing healthcare providers the convenience to activate the solution effortlessly by folding, squeezing, and shaking the container. This design notably decreases time spent on medication preparation, cutting down overall processing time by nearly four minutes per dose while significantly reducing labor requirements.
Moreover, the closed-system design of DUPLEX minimizes contamination risks and reduces medication errors by 54% compared to conventional compounding methods—an essential feature in fast-paced medical environments. The system can be stored at room temperature and requires no thawing, making it highly adaptable for various healthcare settings.
Voices from B. Braun Leadership
Ellen Menard, Corporate Vice President of Marketing Pharma at B. Braun Medical, articulated, "The launch of Piperacillin and Tazobactam in the DUPLEX Drug Delivery System signifies our ongoing support for healthcare professionals, providing them with ready-to-use antibiotic options. This new product aims to reduce waste, optimize space, and simplify the administration process—critical factors for pharmacy and nursing teams managing high-demand antibiotics."
Future Plans for Injectable Drugs
The introduction of Piperacillin and Tazobactam is just the beginning, as B. Braun Medical Inc. has plans to roll out a series of injectable drugs in the upcoming years. This expansion of their portfolio is driven by a dedication to meet the increasing demand for essential medications that enhance patient care. The company is positioning itself to be at the forefront of innovation in the field of smart infusion therapy.
About B. Braun Medical Inc.
B. Braun Medical Inc. is a recognized leader in smart infusion therapies and effective pharmacy solutions aimed at enhancing safety for both patients and providers. The company is devoted to facilitating improved outcomes and satisfaction among patients through its range of products and services. B. Braun operates from its headquarters in Bethlehem, Pennsylvania, as part of a larger group that includes B. Braun Interventional Systems and Aesculap. With over 8,500 employees spread across over 30 locations throughout North America, B. Braun is firmly committed to serving the healthcare needs of communities.
Globally, the B. Braun Group employs more than 64,000 individuals across 64 countries, emphasizing a philosophy of Sharing Expertise. This approach ensures continuous collaboration and knowledge exchange with healthcare partners to confront the pressing challenges of improving care and controlling costs.
Frequently Asked Questions
What is Piperacillin and Tazobactam used for?
Piperacillin and Tazobactam are indicated for the treatment of various infections, including intra-abdominal infections, pneumonia, and skin infections.
What makes the DUPLEX system unique?
The DUPLEX system allows for on-demand activation of medication, minimizing contamination risks and errors compared to traditional methods.
What are the benefits of the new antibiotic launch?
This launch aims to improve workflow efficiency, reduce medication waste, and facilitate faster patient care in critical settings.
How does B. Braun support healthcare professionals?
B. Braun is dedicated to improving health outcomes by developing user-friendly products tailored to the challenging environments healthcare professionals navigate.
What is B. Braun's future outlook?
B. Braun plans to expand its injectable drug portfolio, further solidifying its role in addressing the growing demands of the healthcare industry.
